Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on July 27, 2026

Jul. 27, 2026

CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors

Indeterminate GlobeNewswire

Jul. 27, 2026

Glacier Fresh Launches the “Verified by Science” Initiative to Set a New Standard for Transparent Water Filter Testing

Indeterminate GlobeNewswire

Jul. 27, 2026

Sofwave to Participate in 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Indeterminate GlobeNewswire

Jul. 27, 2026

Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research

Indeterminate GlobeNewswire

Jul. 27, 2026

Capitolis Appoints Ashwath Bhat as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 27, 2026

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

Indeterminate GlobeNewswire

Jul. 27, 2026

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

Indeterminate GlobeNewswire

Jul. 27, 2026

Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference

Indeterminate GlobeNewswire

Jul. 27, 2026

ProStar Appoints Michael Wolff as Chief Executive Officer

Indeterminate GlobeNewswire

Jul. 27, 2026

Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting

Indeterminate GlobeNewswire

Jul. 27, 2026

Swarmer and Brightline Partner on AI Data Collection and Drone Interoperability for U.S. Department of War

Indeterminate GlobeNewswire

Jul. 27, 2026

Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome

Indeterminate GlobeNewswire

Jul. 27, 2026

Synack Researchers and Security Professionals to Speak at Black Hat USA and DEF CON 34

Indeterminate GlobeNewswire

Jul. 27, 2026

EagleNXT Joint Venture “ThirdEye USA” Selected to Participate in EXTiC 26-2 Counter-UAS Experimentation Event

Indeterminate GlobeNewswire

Jul. 27, 2026

Rezolve Ai Delivers Breakout First-Half Performance: Preliminary H1 2026 Revenue Expected to Reach Approximately $127 Million, Nearly 20x H1 2025

Indeterminate GlobeNewswire

Jul. 27, 2026

2Checkout Named Best Payments Solution by Industry Peers at the 2026 CODiE Awards

Indeterminate GlobeNewswire

Jul. 27, 2026

Genius Group Offers Share Loyalty Bonus Program Delivering up to 59% Return on Investment in six months, Closing July 31, 2026.

Indeterminate GlobeNewswire

Jul. 27, 2026

Quantum Cyber Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility in Bridgeport, Connecticut

Indeterminate GlobeNewswire

Jul. 27, 2026

Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Jul. 27, 2026

QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

Indeterminate GlobeNewswire